GGrantIndex
Sort

51,593 grants matching hepatitis

Contributions of hepatic and intestinal pathways to cholesterol excretion

$451,563
Gregory A Graf · University Of Kentucky · R01 · FY2019 · DK

Peripheralized CB1 antagonists for ALD

$451,504
Rangan Maitra · Research Triangle Institute · R01 · FY2014 · AA

Continuous Evolution of Proteins with Novel Therapeutic Potential

$451,488
David R Liu · Harvard University · R01 · FY2016 · EB

Continuous Evolution of Proteins with Novel Therapeutic Potential

$451,488
David R Liu · Broad Institute, Inc. · R01 · FY2019 · EB

Regulation of Liver Growth and Function

$451,487
Leonard S Jefferson · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2010 · DK

Developing Research At The Interface Of HIV And Aging

$451,482
Kevin P. High · Wake Forest University Health Sciences · R24 · FY2014 · AG

Metabolic Regulation in the Acute Phase

$451,472
David Ron · New York University School Of Medicine · R37 · FY2009 · DK

Role of TAZ in metabolic regulation in both normal and insulin resistant states

$451,456
Ji Miao · Boston Children'S Hospital · R01 · FY2022 · DK

Role of TAZ in metabolic regulation in both normal and insulin resistant states

$451,456
Ji Miao · Boston Children'S Hospital · R01 · FY2023 · DK

Mechanistic role of P4501 enzymes in the prevention of PAH carcinogenesis by omega 3 fatty acids

$451,442
Bhagavatula Moorthy · Baylor College Of Medicine · R01 · FY2021 · ES

Virocide as an Anti-HIV Microbicide Candidate

$451,431
Philippe Andre Gallay · Scripps Research Institute, The · R21 · FY2009 · AI

Redox and Proteomic Stress Responses in Biliary Disease

$451,414
Michael A Pack · University Of Pennsylvania · R01 · FY2023 · DK

Peripheralized CB1 antagonists for ALD

$451,404
Rangan Maitra · Research Triangle Institute · R01 · FY2017 · AA

EPIDEMIOLOGY OF CMV

$451,397
Virginia Commonwealth University · R01 · FY2000 · AI

Peripheralized CB1 antagonists for ALD

$451,383
Rangan Maitra · Research Triangle Institute · R01 · FY2016 · AA

4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN: A Phase II Clinical Trial in Adolescents/Young Adults (AYA)with CNS Malignancies

$451,382
Lee Roy Morgan · Dekk-Tec, Inc. · R44 · FY2020 · CA

Preclinical Diagnostic Imaging of Amyloid

$451,374
Jonathan S Wall · University Of Tennessee Knoxville · R01 · FY2010 · DK

Biochemical Mechanisms of In Vivo Insulin Resistance

$451,360
Meredith A Hawkins · Albert Einstein College Of Medicine · R01 · FY2006 · DK

Alcoholic liver disease: Biochemical, cellular and systemic responses to ethanol

$451,359
Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · P20 · FY2012 · AA

Biochemical Mechanisms of In Vivo Insulin Resistance

$451,304
Meredith A Hawkins · Albert Einstein College Of Medicine · R01 · FY2007 · DK

Decoding the Brain-Liver Axis: Uncovering mechanisms of host defense

$451,292
Joni Nikkanen · University Of California Berkeley · DP2 · FY2024 · AI

Studies on Pancreatic Hormones

$451,264
University Of Chicago · R01 · FY2005 · DK

Models for Optimal Liver Transplant Outcomes

$451,259
Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2002 · DK

Accurate Measurement of Renal Function in Cirrhosis

$451,253
Vivian S Lee · University Of Utah · R01 · FY2013 · DK

Testing in vivo of HIV-immunopathogenic hypotheses using new kinetic techniques

$451,177
Marc Kopel Hellerstein · University Of California Berkeley · R37 · FY2012 · AI